ADM and Crohn disease: To illustrate the latter, Juncadella et al. evaluated ADM concentrations in light of several objective therapeutic outcomes: ADM levels of 11.8, 12.0, and 12.2 μg/mL were associated with biochemical, endoscopic or histological remission in patients with Crohn’s disease; respectively [11].